Postoperative serum C-reactive protein levels in non-small cell lung cancer patients

Annals of Thoracic and Cardiovascular Surgery

Volumn 16, Issue 2, 2010, Pages 85-90

  Hara, Masaki ^a   Yonei, Akihiro ^a   Ayabe, Takanori ^a   Tomita, Masaki ^a   Nakamura, Kunihide ^a   Onitsuka, Toshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

C reactive protein; Inflammatory protein; Non small cell lung cancer; Prognosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TUMOR; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 77953501961     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ablij H, Meinders A. C-reactive protein: history and revival. Eur J Intern Med 2002; 13: 412-22.
2. Nikiteas NI, Tzanakis N, Gazouli M, Rallis G, Daniilidis K, et al. Serum IL-6, TNFα and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol 2005; 11: 1639-43
3. Miki C, Konishi N, Ojima E, Hatada T, Inoue Y, et al. C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 2004; 49: 970-6.
4. Gockel I, Dirksen K, Messow CM, Junginger T. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol 2006; 12: 3746-50.
5. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005; 103: 1856-64.
6. Hara M, Matsuzaki Y, Shimizu T, Tomita M, Ayabe T, et al. Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 2007; 27: 3001-4.
7. Heikkilä K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating oncentrations of C reactive protein and cancer. J Epidemiol Community Health 2007; 61: 824-33.
8. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, et al. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 2003; 83: 248-52.
9. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998; 176: 335-8.
10. Matsuguchi T, Okamura S, Kawasaki C, Shimoda K, Omori F, et al. Constitutive production of granulocyte colony-stimulating factor and interleukin-6 by a human lung cancer cell line, KSNY: gene amplification and increased mR NA stability. Eur J Haematol 1991; 47: 128-33.
11. Katsumata N, Eguchi K, Fukuda M, Yamamoto N, Ohe Y, et al. Serum levels of cytokines in patients with untreated primary lung cancer. Clin Cancer Res 1996; 2: 553-9.
12. Niiya M, Niiya K, Kiguchi T, Shibakura M, Asaumi N, et al. Induction of TNF-α, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells. Cancer Chemother Pharmacol 2003; 52: 391-8
13. Tomita M, Matsuzaki Y, Shimizu T, Hara M, Ayabe T, et al. Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels. Thorac Cardiovasc Surg 2005; 53: 300-4.
14. Park YA, Lee KY, Kim NK, Baik SH, Sohn SK, et al. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol 2006; 13: 645-50.
15. Jones JM, McGonigle NC, McAnespie M, Cran GW, Graham AN. Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Lung Cancer 2006; 53: 97-101